1.The median effective dose of ciprofol combined with sufentanil to in-hibit tracheal intubation reaction in patients undergoing intracranial aneurysm embolization
Fangzhou LU ; Meijuan LIU ; Qiong ZENG ; Wenbin ZHANG ; Jun LU
Chinese Journal of Clinical Pharmacology and Therapeutics 2025;30(8):1092-1098
AIM:To investigate the median effec-tive dose of ciprofol combined with sufentanil to in-hibit tracheal intubation reaction in patients under-going intracranial aneurysm embolization.METH-ODS:Forty-five patients who underwent emboliza-tion for intracranial aneurysms were divided into two groups according to age:non-elderly group(aged 18-64 years)and elderly group(aged>65 years).Patients in the two groups were first given intravenous ciprofol,of which the initial dose of cip-rofol was 0.4 mg/kg and sufentanil 0.3 μg/kg and rocuronium 0.6 mg/kg were respectively injected according to BIS value and modified observer's as-sessment of alertness and sedation(MOAA/S)score.Then,endotracheal intubation was defined as 3 minutes after the induction of the study drug.Dixon sequential method was adopted,and the dose of ciprofol for the next patient was deter-mined according to whether the tracheal intuba-tion reaction was positive(Positive reaction of tra-cheal intubation was defined as the patient's kino-motor reaction such as coughing during tracheal in-tubation or the increase of MAP or HR within 2 minutes after intubation was greater than 20%of the basic value).When the tracheal intubation indi-cated a positive response,the next patient was raised by one gradient,otherwise,it was lowered by one gradient until the study ended at 7 crosses.The common dose ratio of adjacent patients was 1∶1.1.The Probit probability method was used to cal-culate the 50%effective dose(ED50),95%effective dose(ED95)and the corresponding 95%confidence interval(CI)of ciprofol.Perioperative adverse reac-tions were recorded in both groups.RESULTS:In the non-elderly group,the ED50 of ciprofol inhibit-ing positive tracheal intubation reaction was 0.472 mg/kg(95%CI 0.419-0.565 mg/kg),and the ED95 was 0.567 mg/kg(95%CI 0.513-1.293 mg/kg).In the elderly group,the ED50 of ciprofol inhibiting tra-cheal intubation reaction was 0.409 mg/kg(95%CI 0.383-0.434 mg/kg)and the ED95 was 0.452 mg/kg(95%CI 0.430-0.591 mg/kg).CONCLUSION:The ED50 of ciprofol combined with sufentanil inhibiting positive tracheal intubation reaction was 0.472 mg/kg in non-elderly patients and 0.409 mg/kg in elder-ly patients.
2.Panorama of Organoid Technologies in Chinese Medicine:Opportunities and Challenges from Basic Mechanisms to Clinical Practice
Rui HUANG ; Lianlin SU ; De JI ; Fangzhou YIN ; Tulin LU ; Yi SHAO ; Lin LI
Journal of Nanjing University of Traditional Chinese Medicine 2025;41(7):856-868
By systematically reviewing the development history of organoid technology and its application examples in Chinese med-icine,this paper summarizes the specific applications of organoids in the mechanism and translation of Chinese medicine,pathological mechanisms,diagnostic techniques,and therapeutic strategies,and evaluate their advantages and limitations through literature analysis.Organoid technology provides an in vitro model that highly simulates the function of human organs for TCM research,and can simulate the multi-target and multi-pathway mechanism of action of TCM,which significantly improves the scientificity and precision of TCM in the analysis of disease mechanisms,drug screening and personalized treatment.However,it still faces challenges in stand-ardization,ethical regulation,and clinical translation.The combination of organoid technology and TCM has a broad prospect,and it is necessary to further optimize the model construction,resolve ethical issues,and promote its wide application in TCM research and clin-ical practice through technological innovation,interdisciplinary cooperation,and international regulatory coordination in the future.
3.Panorama of Organoid Technologies in Chinese Medicine:Opportunities and Challenges from Basic Mechanisms to Clinical Practice
Rui HUANG ; Lianlin SU ; De JI ; Fangzhou YIN ; Tulin LU ; Yi SHAO ; Lin LI
Journal of Nanjing University of Traditional Chinese Medicine 2025;41(7):856-868
By systematically reviewing the development history of organoid technology and its application examples in Chinese med-icine,this paper summarizes the specific applications of organoids in the mechanism and translation of Chinese medicine,pathological mechanisms,diagnostic techniques,and therapeutic strategies,and evaluate their advantages and limitations through literature analysis.Organoid technology provides an in vitro model that highly simulates the function of human organs for TCM research,and can simulate the multi-target and multi-pathway mechanism of action of TCM,which significantly improves the scientificity and precision of TCM in the analysis of disease mechanisms,drug screening and personalized treatment.However,it still faces challenges in stand-ardization,ethical regulation,and clinical translation.The combination of organoid technology and TCM has a broad prospect,and it is necessary to further optimize the model construction,resolve ethical issues,and promote its wide application in TCM research and clin-ical practice through technological innovation,interdisciplinary cooperation,and international regulatory coordination in the future.
4.Advances in stem cell therapy for islet function remodeling
Sijie ZHANG ; Fangzhou LU ; Qi FU ; Tao YANG
Chinese Journal of Endocrinology and Metabolism 2025;41(10):878-882
Diabetes mellitus, primarily caused by insulin deficiency or insulin resistance, is a metabolic disorder characterized by hyperglycemia. It has become a global public health priority. In addressing the core issue of pancreatic dysfunction, the limitations of traditional treatments have become increasingly apparent, leading to a growing interest in novel strategies for islet function remodeling. With advancements in stem cell technology, stem cell therapy is emerging as a promising approach for islet function restoration. This review summarizes recent progress in stem cell therapy for islet function remodeling, with a particular focus on the application of stem cell technology to in vitro islet reconstruction, offering new insights for the development of efficient and safe therapeutic strategies for diabetes.
5.The median effective dose of ciprofol combined with sufentanil to in-hibit tracheal intubation reaction in patients undergoing intracranial aneurysm embolization
Fangzhou LU ; Meijuan LIU ; Qiong ZENG ; Wenbin ZHANG ; Jun LU
Chinese Journal of Clinical Pharmacology and Therapeutics 2025;30(8):1092-1098
AIM:To investigate the median effec-tive dose of ciprofol combined with sufentanil to in-hibit tracheal intubation reaction in patients under-going intracranial aneurysm embolization.METH-ODS:Forty-five patients who underwent emboliza-tion for intracranial aneurysms were divided into two groups according to age:non-elderly group(aged 18-64 years)and elderly group(aged>65 years).Patients in the two groups were first given intravenous ciprofol,of which the initial dose of cip-rofol was 0.4 mg/kg and sufentanil 0.3 μg/kg and rocuronium 0.6 mg/kg were respectively injected according to BIS value and modified observer's as-sessment of alertness and sedation(MOAA/S)score.Then,endotracheal intubation was defined as 3 minutes after the induction of the study drug.Dixon sequential method was adopted,and the dose of ciprofol for the next patient was deter-mined according to whether the tracheal intuba-tion reaction was positive(Positive reaction of tra-cheal intubation was defined as the patient's kino-motor reaction such as coughing during tracheal in-tubation or the increase of MAP or HR within 2 minutes after intubation was greater than 20%of the basic value).When the tracheal intubation indi-cated a positive response,the next patient was raised by one gradient,otherwise,it was lowered by one gradient until the study ended at 7 crosses.The common dose ratio of adjacent patients was 1∶1.1.The Probit probability method was used to cal-culate the 50%effective dose(ED50),95%effective dose(ED95)and the corresponding 95%confidence interval(CI)of ciprofol.Perioperative adverse reac-tions were recorded in both groups.RESULTS:In the non-elderly group,the ED50 of ciprofol inhibit-ing positive tracheal intubation reaction was 0.472 mg/kg(95%CI 0.419-0.565 mg/kg),and the ED95 was 0.567 mg/kg(95%CI 0.513-1.293 mg/kg).In the elderly group,the ED50 of ciprofol inhibiting tra-cheal intubation reaction was 0.409 mg/kg(95%CI 0.383-0.434 mg/kg)and the ED95 was 0.452 mg/kg(95%CI 0.430-0.591 mg/kg).CONCLUSION:The ED50 of ciprofol combined with sufentanil inhibiting positive tracheal intubation reaction was 0.472 mg/kg in non-elderly patients and 0.409 mg/kg in elder-ly patients.
6.Advances in stem cell therapy for islet function remodeling
Sijie ZHANG ; Fangzhou LU ; Qi FU ; Tao YANG
Chinese Journal of Endocrinology and Metabolism 2025;41(10):878-882
Diabetes mellitus, primarily caused by insulin deficiency or insulin resistance, is a metabolic disorder characterized by hyperglycemia. It has become a global public health priority. In addressing the core issue of pancreatic dysfunction, the limitations of traditional treatments have become increasingly apparent, leading to a growing interest in novel strategies for islet function remodeling. With advancements in stem cell technology, stem cell therapy is emerging as a promising approach for islet function restoration. This review summarizes recent progress in stem cell therapy for islet function remodeling, with a particular focus on the application of stem cell technology to in vitro islet reconstruction, offering new insights for the development of efficient and safe therapeutic strategies for diabetes.
7.Genetic characterization and potential transmission risk of novel IncpGRT1 plasmids from Pseudomonas species
Xinyue Li ; Peng Wang ; Fangzhou Chen ; Xiaofei Mu ; Xiuhui Lu ; Jiaqi He ; Yali Zheng
Acta Universitatis Medicinalis Anhui 2023;58(8):1261-1266
Objective :
To analyze the genome structure and genetic characteristics of IncpGRT1 plasmids from Pseud⁃
omonas , and elucidate its potential transmission risk .
Methods :
The genomic DNA of the clinical isolate 15420352 was extracted after purification and preservation of the strain , and then the whole genome was sequenced , and then the type of the plasmid was identified . Sequence annotation and comparison of the backbone region and the accessory modules were performed on all five same type sequenced plasmids , including one plasmid p420352 - strA in this
study and four from GenBank . The plasmids were annotated by RAST , Plasmidfinder , Blast , ResFinder , and ISfinder. The ORFs of the plasmid were annotated and drug resistance genes were found .
Results :
All five plasmids were classified as new IncpGRT1 type plasmids . The IncpGRT1 backbone genes or gene loci were in all five plasmids , and they contained an auxiliary replicon besides the primary IncpGRT1 replicon . Five IncpGRT1 plasmids carried at least three different accessory modules , including the srp region , the msr region , and a Tn5053 family transposon . Three
resistance genes strA , strB , and mer were obtained in these plasmids , which were involved in resistance to two categories of antibiotics and heavy metals . We also found that these plasmids carried at least one virulence gene msr and five key transporters srp , emrE , mod , phn , and lpt , which could improve the environmental adaptability of the strains .
Conclusion
The IncpGRT1 plasmids have become the important vector for the accumulation and spread of some drug resistance genes and virulence genes in Pseudomonas , and have improved the environmental adaptability of the strain.
8.Progress of advanced hepatocellular carcinoma adoptive cell therapy based on tumor neoantigens
Fangzhou WANG ; Wenwen ZHANG ; Chonghui LI ; Shichun LU
Chinese Journal of Hepatobiliary Surgery 2022;28(9):708-712
Advanced hepatocellular carcinoma has a high degree of malignancy and poor prognosis. Studies showed that there is a close relationship between the progression of hepatocellular carcinoma and the immune status in tumor microenvironment. Adoptive cell therapy showed anti-tumor effects and improve immunosuppression by infusing patients with activated specific immune cells, which become a central issue in tumor therapy and shown promising effects in the treatment of various malignant tumors, indicating great application potential. Adoptive cell therapy based on neoantigen may become a new hot spot in the treatment of hepatocellular carcinoma, and their application, safety and effectiveness evaluation, efficacy prediction and assessment have become urgent issues to be solved. The purpose of this article is to introduce the progress related to adoptive cell therapy for advanced hepatocellular carcinoma and elaborate the problems that need to be solved in the future.
9. Research progress of ketamine psychomimetic symptoms and reward mechanism
Hang YANG ; Chun YANG ; Wei ZHU ; Fangzhou LU
Chinese Journal of Clinical Pharmacology and Therapeutics 2022;27(12):1347-1353
Ketamine is a non-selective N-methyl-D-aspartic acid (NMDA) receptor antagonist. Ketamine plays a significant role in the treatment and research of neuropsychiatric diseases in recent years. The neural mechanism of ketamine psychogenic effects and reward pathway remains to be perfected, which may be closely related to a variety of neurons and pathways in the brain. This paper intends to review the relevant studies at home and abroad, and try to integrate the known neural mechanisms and put forward reasonable hypotheses.
10.A Three-Dimensional Deep Convolutional Neural Network for Automatic Segmentation and Diameter Measurement of Type B Aortic Dissection
Yitong YU ; Yang GAO ; Jianyong WEI ; Fangzhou LIAO ; Qianjiang XIAO ; Jie ZHANG ; Weihua YIN ; Bin LU
Korean Journal of Radiology 2021;22(2):168-178
Objective:
To provide an automatic method for segmentation and diameter measurement of type B aortic dissection (TBAD).
Materials and Methods:
Aortic computed tomography angiographic images from 139 patients with TBAD were consecutively collected. We implemented a deep learning method based on a three-dimensional (3D) deep convolutional neural (CNN) network, which realizes automatic segmentation and measurement of the entire aorta (EA), true lumen (TL), and false lumen (FL). The accuracy, stability, and measurement time were compared between deep learning and manual methods. The intra- and inter-observer reproducibility of the manual method was also evaluated.
Results:
The mean dice coefficient scores were 0.958, 0.961, and 0.932 for EA, TL, and FL, respectively. There was a linear relationship between the reference standard and measurement by the manual and deep learning method (r = 0.964 and 0.991, respectively). The average measurement error of the deep learning method was less than that of the manual method (EA, 1.64% vs. 4.13%; TL, 2.46% vs. 11.67%; FL, 2.50% vs. 8.02%). Bland-Altman plots revealed that the deviations of the diameters between the deep learning method and the reference standard were -0.042 mm (-3.412 to 3.330 mm), -0.376 mm (-3.328 to 2.577 mm), and 0.026 mm (-3.040 to 3.092 mm) for EA, TL, and FL, respectively. For the manual method, the corresponding deviations were -0.166 mm (-1.419 to 1.086 mm), -0.050 mm (-0.970 to 1.070 mm), and -0.085 mm (-1.010 to 0.084 mm). Intra- and inter-observer differences were found in measurements with the manual method, but not with the deep learning method. The measurement time with the deep learning method was markedly shorter than with the manual method (21.7 ± 1.1 vs. 82.5 ± 16.1 minutes, p < 0.001).
Conclusion
The performance of efficient segmentation and diameter measurement of TBADs based on the 3D deep CNN was both accurate and stable. This method is promising for evaluating aortic morphology automatically and alleviating the workload of radiologists in the near future.


Result Analysis
Print
Save
E-mail